PubMed

Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction.

Lee VC, Rhew DC, Dylan M, Badamgarav E, Braunstein GD, Weingarten SR.

Ann Intern Med. 2004 Nov 2;141(9):693-704. Erratum in: Ann Intern Med. 2005 Mar 1;42(5):391. Dosage error in article text. PMID: 15520426 [PubMed - indexed for MEDLINE]Related articlesFree article

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.PMID: 16259523 [PubMed - indexed for MEDLINE]Related articles

Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.

Epstein BJ, Gums JG.

Ann Pharmacother. 2005 Mar;39(3):470-80. Epub 2005 Feb 8. Review.PMID: 15701766 [PubMed - indexed for MEDLINE]Related articles

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

[No authors listed]

Prescrire Int. 2005 Oct;14(79):180-6.PMID: 16285075 [PubMed - indexed for MEDLINE]Related articles

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.

Kunz R, Friedrich C, Wolbers M, Mann JF.

Ann Intern Med. 2008 Jan 1;148(1):30-48. Epub 2007 Nov 5.PMID: 17984482 [PubMed - indexed for MEDLINE]Related articlesFree article

Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.

Volpe M, Tocci G, Sciarretta S, Verdecchia P, Trimarco B, Mancia G.

J Hypertens. 2009 May;27(5):941-6.PMID: 19381108 [PubMed - indexed for MEDLINE]Related articles

Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials.

Jong P, Demers C, McKelvie RS, Liu PP.

J Am Coll Cardiol. 2002 Feb 6;39(3):463-70.PMID: 11823085 [PubMed - indexed for MEDLINE]Related articles

The renin-angiotensin system: the role of inhibitors, blockers, and genetic polymorphisms in the treatment and prevention of heart failure.

Hebert PR, Foody JM, Hennekens CH.

Curr Vasc Pharmacol. 2003 Mar;1(1):33-9. Review.PMID: 15320851 [PubMed - indexed for MEDLINE]Related articles

Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers.

Pfeffer MA.

Am Heart J. 2000 Jan;139(1 Pt 2):S23-8. Review.PMID: 10618584 [PubMed - indexed for MEDLINE]Related articles

Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.

Ghali JK, Tam SW, Ferdinand KC, Lindenfeld J, Sabolinski ML, Taylor AL, Worcel M, Curry CL, Cohn JN; A-HeFT Investigators.

Am J Cardiovasc Drugs. 2007;7(5):373-80.PMID: 18041162 [PubMed - indexed for MEDLINE]Related articles

Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker).

Dimopoulos K, Salukhe TV, Coats AJ, Mayet J, Piepoli M, Francis DP.

Int J Cardiol. 2004 Feb;93(2-3):105-11.PMID: 14975535 [PubMed - indexed for MEDLINE]Related articles

Debate: angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers--a gap in evidence-based medicine.

Ball SG, White WB.

Am J Cardiol. 2003 May 22;91(10A):15G-21G. Review.PMID: 12781904 [PubMed - indexed for MEDLINE]Related articles

Risk-treatment mismatch in the pharmacotherapy of heart failure.

Lee DS, Tu JV, Juurlink DN, Alter DA, Ko DT, Austin PC, Chong A, Stukel TA, Levy D, Laupacis A.

JAMA. 2005 Sep 14;294(10):1240-7.PMID: 16160132 [PubMed - indexed for MEDLINE]Related articlesFree article

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

Garg R, Yusuf S.

JAMA. 1995 May 10;273(18):1450-6. Erratum in: JAMA 1995 Aug 9;274(6):462. PMID: 7654275 [PubMed - indexed for MEDLINE]Related articles

Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.

Majumdar SR, McAlister FA, Cree M, Chang WC, Packer M, Armstrong PW; ATLAS Study Group.

Clin Ther. 2004 May;26(5):694-703.PMID: 15220013 [PubMed - indexed for MEDLINE]Related articles

Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.

Krum H, Haas SJ, Eichhorn E, Ghali J, Gilbert E, Lechat P, Packer M, Roecker E, Verkenne P, Wedel H, Wikstrand J.

Eur Heart J. 2005 Oct;26(20):2154-8. Epub 2005 Jul 13. Review.PMID: 16014644 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease.

Mancini GB, Etminan M, Zhang B, Levesque LE, FitzGerald JM, Brophy JM.

J Am Coll Cardiol. 2006 Jun 20;47(12):2554-60. Epub 2006 May 2.PMID: 16781387 [PubMed - indexed for MEDLINE]Related articles

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR.

Clin Ther. 2007 Sep;29(9):1803-24. Review.PMID: 18035185 [PubMed - indexed for MEDLINE]Related articles

RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.

Werner C, Baumhäkel M, Teo KK, Schmieder R, Mann J, Unger T, Yusuf S, Böhm M.

Clin Res Cardiol. 2008 Jul;97(7):418-31. Epub 2008 May 3. Review.PMID: 18454336 [PubMed - indexed for MEDLINE]Related articles

Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.

Tokmakova M, Solomon SD.

Curr Opin Cardiol. 2006 Jul;21(4):268-72. Review.PMID: 16755193 [PubMed - indexed for MEDLINE]Related articles